KR860001339B1 - 피리다지논 유도체의 제조방법 - Google Patents

피리다지논 유도체의 제조방법 Download PDF

Info

Publication number
KR860001339B1
KR860001339B1 KR1019830002710A KR830002710A KR860001339B1 KR 860001339 B1 KR860001339 B1 KR 860001339B1 KR 1019830002710 A KR1019830002710 A KR 1019830002710A KR 830002710 A KR830002710 A KR 830002710A KR 860001339 B1 KR860001339 B1 KR 860001339B1
Authority
KR
South Korea
Prior art keywords
pyridazinone
compound
hydrogen
och
blood flow
Prior art date
Application number
KR1019830002710A
Other languages
English (en)
Korean (ko)
Other versions
KR840005105A (ko
Inventor
쉬브레 앙리
Original Assignee
떼아(떼라뾔띠끄 에 아쁠리까시용) 쏘씨에떼 아노님
쟝 쉬브레
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 떼아(떼라뾔띠끄 에 아쁠리까시용) 쏘씨에떼 아노님, 쟝 쉬브레 filed Critical 떼아(떼라뾔띠끄 에 아쁠리까시용) 쏘씨에떼 아노님
Publication of KR840005105A publication Critical patent/KR840005105A/ko
Application granted granted Critical
Publication of KR860001339B1 publication Critical patent/KR860001339B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/32—Oxygen atoms
    • C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1019830002710A 1982-06-18 1983-06-17 피리다지논 유도체의 제조방법 KR860001339B1 (ko)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8210630 1982-06-18
FR8210630A FR2528837A1 (fr) 1982-06-18 1982-06-18 Arylacetyl butanolides et leurs derives pyridazinones utilisables comme medicaments, et procedes pour leur fabrication

Publications (2)

Publication Number Publication Date
KR840005105A KR840005105A (ko) 1984-11-03
KR860001339B1 true KR860001339B1 (ko) 1986-09-15

Family

ID=9275129

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019830002710A KR860001339B1 (ko) 1982-06-18 1983-06-17 피리다지논 유도체의 제조방법

Country Status (10)

Country Link
JP (1) JPS5910571A (de)
KR (1) KR860001339B1 (de)
BE (1) BE897085A (de)
CH (1) CH657125B (de)
DE (1) DE3321772A1 (de)
FR (1) FR2528837A1 (de)
GB (1) GB2122195A (de)
GR (1) GR78284B (de)
IT (1) IT1194281B (de)
NL (1) NL8302087A (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4666902A (en) * 1983-06-20 1987-05-19 Cassella Aktiengesellschaft Tetrahydropyridazinone derivatives, processes for their preparation and their use
EP0210530A1 (de) * 1985-07-27 1987-02-04 MERCK PATENT GmbH 6-Arylalkenylpyridazinone
JPS63220512A (ja) * 1987-03-09 1988-09-13 松下電器産業株式会社 電解コンデンサ用電極箔
JPH04100106U (de) * 1991-02-12 1992-08-28
JPH0776050B2 (ja) * 1991-07-25 1995-08-16 実 近藤 ワークの移送装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2304977A1 (de) * 1973-02-01 1974-08-08 Basf Ag Neue dihydropyridazinone

Also Published As

Publication number Publication date
FR2528837A1 (fr) 1983-12-23
KR840005105A (ko) 1984-11-03
JPS5910571A (ja) 1984-01-20
CH657125B (de) 1986-08-15
FR2528837B1 (de) 1984-12-07
DE3321772A1 (de) 1983-12-22
IT8321684A0 (it) 1983-06-17
NL8302087A (nl) 1984-01-16
BE897085A (fr) 1983-12-19
GB2122195A (en) 1984-01-11
IT1194281B (it) 1988-09-14
GB8316516D0 (en) 1983-07-20
GR78284B (de) 1984-09-26

Similar Documents

Publication Publication Date Title
JP3190340B2 (ja) 酸化窒素供与体プロドラッグとしての求核試薬−酸化窒素付加物の酸素置換誘導体
JPS6267081A (ja) Ｐａｆきつ抗剤としての新規な２，５−ジアリ−ルテトラヒドロチオフエン類及びその類縁体
JPS5995269A (ja) 抗てんかん性医薬品
FI67543C (fi) Foerfarande foer framstaellning av farmakologiskt aktiv 2-(2-(1,4-benzodioxanyl))-2-imidazolin
JPH04217977A (ja) 新規なベンゾオキサジン及びベンゾチアジン誘導体及びその製造方法
JPS5822119B2 (ja) ジチオ−ル誘導体
JPS6028979A (ja) イミダゾキナゾリン類化合物
JPS6230780A (ja) １，７−ナフチリジン誘導体及びこれを含有する薬剤
KR860001339B1 (ko) 피리다지논 유도체의 제조방법
JPS58501324A (ja) ２−〔２′　−ヒドロキシ−３′　−（１，１−ジメチルプロピルアミノ）−プロポキシ〕−β−フェニルプロピオフェノン、その酸付加塩、その製造法および医薬組成物
CA2149691A1 (en) Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia
CH640227A5 (de) Aminoalkoxyphenyl-derivate.
KR900005010B1 (ko) 5-아실-2-(1h)-피리디논 및 이의 제조방법
US4600710A (en) β-Adrenergic receptor agonist alkylaminoalkyl pyridinemethanol derivatives
JPS60158190A (ja) ヒダントイン誘導体およびその製法ならびにそれを含有する医薬
US4512994A (en) Long-acting theophylline in medicinal form
FR2499853A1 (fr) Agents cardiotoniques, a base de derives du 5-phenylthiazole et composition pharmaceutique contenant un tel agent
JPS62161768A (ja) ３（２ｈ）―ピリダジノン誘導体及びこれを含む薬剤組成物
NL8004565A (nl) Eburnaanderivaten en werkwijze voor het bereiden van deze eburnaanderivaten alsmede de toepassing hiervan in geneesmiddelen met een vaatverwijdende werking.
JPH0680041B2 (ja) ２−ピリジル酢酸誘導体、その製法およびそれを含む医薬
US4148898A (en) N-oxy-ajmaline and the use thereof in treating cardiovascular disorders
NL8200746A (nl) Verbinding met antitussive activiteit, werkwijze ter bereiding daarvan en toepassing.
CA1227220A (en) 3-amino-1 phenoxy-2-propanol derivatives
US3868463A (en) Method of treating arrhythmia
JPS58219160A (ja) 特に心臓血管系において活性であるトリプタミンの新しい誘導体、およびこの物質の合成方法、およびこの物質を含む薬品

Legal Events

Date Code Title Description
E701 Decision to grant or registration of patent right